Jason Lettmann, Director at Ra Pharmaceuticals, Inc. (RARX), sold 394,263 shares at $13.00 ($5.1M) on 2016-10-31, disclosed to the SEC on 2016-10-31.
Open-market sale of $5.1M RARX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 340 | $4K | 0.1% |
| 2 | $13.00 | 15,633 | $203K | 4.0% |
| 3 | $13.00 | 114,752 | $1.5M | 29.1% |
| 4 | $13.00 | 263,538 | $3.4M | 66.8% |
| Total | $13.00 avg | 394,263 | $5.1M | 100% |
| Filing → |
| ALXO | BUY | 2025-09-18 | $176K | — | Filing → |
| ALXO | SELL | 2025-08-19 | $2K | — | Filing → |
| ALXO | SELL | 2025-02-21 | $2K | — | Filing → |